세계의 동공측정계 시장(2023-2030년)

Global Pupillometer Market Size, Share & Trends Analysis Report by Type (Digital, and Video), by Application (Ophthalmology, Neurology, Oncology, and Others) and by End User (Hospitals, Eye Clinics, and Others), Forecast Period (2023-2030)

The global pupillometer market is anticipated to grow at a CAGR of 6.9% during the forecast period (2023-2030). The market's growth is attributed to the growing demand in healthcare across the globe. In healthcare, it contains an increasing demand for reliable and efficient diagnostic tools, particularly in sectors such as ophthalmology, neurology, and critical care. The pupillometers are essential in diagnosing neurological diseases, brain traumas, and monitoring patients in critical care situations. For instance, in Augut 2020, Topcon Healthcare launched its new Aladdin-M instrument. Aladdin-M integrates corneal topography, pupillometry, and optical biometry to assess corneal curvature, pupil dynamics, and axial length metrics reliably.

Segmental Outlook

The global pupillometer market is segmented on the type, application, and end user. Based on the type, the market is sub-segmented into digital, and video. Based on the application, the market is sub-segmented into ophthalmology, neurology, oncology, and others. Furthermore, on the basis of end user, the market is sub-segmented into hospitals, eye clinics, and others. The ophthalmology subcategory is expected to capture a significant portion of the market share within the application segment. The growth can be attributed to the demand for precision in eye surgeries is driven by the requirement for accurate measurements and meticulous planning in refractive surgeries and cataract procedures. This has led to an increased interest in systems such as, SeeNa, that aid surgeons in achieving the optimal surgical outcomes possible. For instance, in October 2023, Bausch + Lomb Corp. launched the SeeNa optical biometry and topography system for refractive cataract patients.

The Neurology Sub-Segment is Anticipated to Hold a Considerable Share of the global Pupillometer Market

Among the application, the neurology sub-segment is expected to hold a considerable share of the global Pupillometer market. The segmental growth is attributed to the increasing neurological disorders. The rising prevalence of neurological conditions and traumatic brain injuries needs for the utilization of precise diagnostic equipment such as pupillometers to perform prompt examinations and therapies. For instane, in February 2021, NeurOptics launched Pupillometry Education Symposiums platform, that includes a series of both product and clinical-focused presentations that demonstrate the essential role pupillometry and the neurological pupil index (NPi) play in the assessment and screening of patients at risk of neurological injury.

Regional Outlook

The global pupillometer market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the increasing availability of pupillometers in the region via a range of websites and vendors is projected to drive market expansion.

The North America Region is Expected to Grow at a Significant CAGR in the global Pupillometer Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the increasing clinical demand across the region. The data revealing potential associations between radiographic indicators and neurological disorders underscore the importance of precise diagnosis methods. Pupillometers, that can independently quantify pupil responsiveness, have been increasingly useful in neurological examinations for disorders such as IPH and ischemic stroke. According to the National Institute of health (gov.) in December 2022, as per the study among the 53 patients with 74 CT images, 49.1% were female, with a median age of 67 years. The patients with IPH showed greater MLS-SP and PGS compared to patients with ischemic stroke, with measurements of 6.2 mm versus 4.0 mm and 5.6 mm versus 3.4 mm, respectively. The study found no significant association between pupil reactivity and radiographic shift markers, but potential relationships were found between MLS-SP and Diff NPi in the IPH and ischemic stroke cohorts. This suggests that the connection between midline shift and asymmetric pupil reactivity varies between IPH and ischemic stroke, emphasizing the need for additional prospective research.

Market Players Outlook

The major companies serving the pupillometer market includes HAMAMATSU Group, HEINE Optotechnik GmbH & Co. KG, Johnson & Johnson Vision Care, Inc., KARL STORZ, Konan Medical USA Inc. and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2021,NeurOptics, launched NPi-300 Pupillometer in the US. The NPi-300 Pupillometer is a versatile tool for neurological examination in both adults and pediatric patients, covering a wide range of diagnoses such as traumatic brain injury, stroke, seizure, and other medical conditions.

The Report Covers:

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global pupillometer market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Dragerwerk AG & Co. KGaA
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. Essilor Ltd.
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Haag-Streit AG
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Pupillometer Market by Type
  • 4.1.1. Digital
  • 4.1.2. Video
• 4.2. Global Pupillometer Market by Application
  • 4.2.1. Ophthalmology
  • 4.2.2. Neurology
  • 4.2.3. Oncology
  • 4.2.4. Others (Anesthesiology and Critical Care, and Trauma and Emergency Medicine)
• 4.3. Global Pupillometer Market by End User
  • 4.3.1. Hospitals
  • 4.3.2. Eye Clinics
  • 4.3.3. Others (Research Institutions and Universities, and Pharmaceutical Companies and Clinical Research Organizations (CROs))

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. Good-Lite Company
• 6.2. HAMAMATSU Group
• 6.3. HEINE Optotechnik GmbH & Co. KG
• 6.4. Johnson & Johnson Vision Care, Inc.
• 6.5. KARL STORZ,
• 6.6. Konan Medical USA Inc.
• 6.7. NeurOptics Inc.
• 6.8. NIDEK CO., LTD.
• 6.9. Procyon TechSolutions
• 6.10. Reichert Inc.
• 6.11. SCHWIND eye-tech-solutions GmbH
• 6.12. Takagi Ophthalmic Instruments Europe Ltd.
• 6.13. US Ophthalmic.
• 6.14. VISIONIX USA INC.